Metabolite profile of a mouse model of Charcot–Marie–Tooth type 2D neuropathy: implications for disease mechanisms and interventions
Charcot–Marie–Tooth disease encompasses a genetically heterogeneous class of heritable polyneuropathies that result in axonal degeneration in the peripheral nervous system. Charcot–Marie–Tooth type 2D neuropathy (CMT2D) is caused by dominant mutations in glycyl tRNA synthetase (GARS). Mutations in t...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Company of Biologists
2016-07-01
|
| Series: | Biology Open |
| Subjects: | |
| Online Access: | http://bio.biologists.org/content/5/7/908 |
| _version_ | 1818439999814631424 |
|---|---|
| author | Preeti Bais Kirk Beebe Kathryn H. Morelli Meagan E. Currie Sara N. Norberg Alexei V. Evsikov Kathy E. Miers Kevin L. Seburn Velina Guergueltcheva Ivo Kremensky Albena Jordanova Carol J. Bult Robert W. Burgess |
| author_facet | Preeti Bais Kirk Beebe Kathryn H. Morelli Meagan E. Currie Sara N. Norberg Alexei V. Evsikov Kathy E. Miers Kevin L. Seburn Velina Guergueltcheva Ivo Kremensky Albena Jordanova Carol J. Bult Robert W. Burgess |
| author_sort | Preeti Bais |
| collection | DOAJ |
| description | Charcot–Marie–Tooth disease encompasses a genetically heterogeneous class of heritable polyneuropathies that result in axonal degeneration in the peripheral nervous system. Charcot–Marie–Tooth type 2D neuropathy (CMT2D) is caused by dominant mutations in glycyl tRNA synthetase (GARS). Mutations in the mouse Gars gene result in a genetically and phenotypically valid animal model of CMT2D. How mutations in GARS lead to peripheral neuropathy remains controversial. To identify putative disease mechanisms, we compared metabolites isolated from the spinal cord of Gars mutant mice and their littermate controls. A profile of altered metabolites that distinguish the affected and unaffected tissue was determined. Ascorbic acid was decreased fourfold in the spinal cord of CMT2D mice, but was not altered in serum. Carnitine and its derivatives were also significantly reduced in spinal cord tissue of mutant mice, whereas glycine was elevated. Dietary supplementation with acetyl-L-carnitine improved gross motor performance of CMT2D mice, but neither acetyl-L-carnitine nor glycine supplementation altered the parameters directly assessing neuropathy. Other metabolite changes suggestive of liver and kidney dysfunction in the CMT2D mice were validated using clinical blood chemistry. These effects were not secondary to the neuromuscular phenotype, as determined by comparison with another, genetically unrelated mouse strain with similar neuromuscular dysfunction. However, these changes do not seem to be causative or consistent metabolites of CMT2D, because they were not observed in a second mouse Gars allele or in serum samples from CMT2D patients. Therefore, the metabolite ‘fingerprint’ we have identified for CMT2D improves our understanding of cellular biochemical changes associated with GARS mutations, but identification of efficacious treatment strategies and elucidation of the disease mechanism will require additional studies. |
| first_indexed | 2024-12-14T18:05:23Z |
| format | Article |
| id | doaj.art-f50e94aa3a7b4091bc4b66563eca9a9c |
| institution | Directory Open Access Journal |
| issn | 2046-6390 |
| language | English |
| last_indexed | 2024-12-14T18:05:23Z |
| publishDate | 2016-07-01 |
| publisher | The Company of Biologists |
| record_format | Article |
| series | Biology Open |
| spelling | doaj.art-f50e94aa3a7b4091bc4b66563eca9a9c2022-12-21T22:52:22ZengThe Company of BiologistsBiology Open2046-63902016-07-015790892010.1242/bio.019273019273Metabolite profile of a mouse model of Charcot–Marie–Tooth type 2D neuropathy: implications for disease mechanisms and interventionsPreeti Bais0Kirk Beebe1Kathryn H. Morelli2Meagan E. Currie3Sara N. Norberg4Alexei V. Evsikov5Kathy E. Miers6Kevin L. Seburn7Velina Guergueltcheva8Ivo Kremensky9Albena Jordanova10Carol J. Bult11Robert W. Burgess12 The Jackson Laboratory, Bar Harbor, 04609 ME, USA Metabolon Inc., Durham, 27713 NC, USA The Jackson Laboratory, Bar Harbor, 04609 ME, USA The Jackson Laboratory, Bar Harbor, 04609 ME, USA The Jackson Laboratory, Bar Harbor, 04609 ME, USA The Jackson Laboratory, Bar Harbor, 04609 ME, USA The Jackson Laboratory, Bar Harbor, 04609 ME, USA The Jackson Laboratory, Bar Harbor, 04609 ME, USA Department of Neurology, Medical University-Sofia, 1431 Sofia, Bulgaria National Genetics Laboratory, Department of Obstetrics and Gynecology, University Hospital of Obstetrics and Gynecology, Medical University-Sofia, 1431 Sofia, Bulgaria Molecular Neurogenomics Group, VIB Department of Molecular Genetics, University of Antwerp, 2610 Antwerpen, Belgium The Jackson Laboratory, Bar Harbor, 04609 ME, USA The Jackson Laboratory, Bar Harbor, 04609 ME, USA Charcot–Marie–Tooth disease encompasses a genetically heterogeneous class of heritable polyneuropathies that result in axonal degeneration in the peripheral nervous system. Charcot–Marie–Tooth type 2D neuropathy (CMT2D) is caused by dominant mutations in glycyl tRNA synthetase (GARS). Mutations in the mouse Gars gene result in a genetically and phenotypically valid animal model of CMT2D. How mutations in GARS lead to peripheral neuropathy remains controversial. To identify putative disease mechanisms, we compared metabolites isolated from the spinal cord of Gars mutant mice and their littermate controls. A profile of altered metabolites that distinguish the affected and unaffected tissue was determined. Ascorbic acid was decreased fourfold in the spinal cord of CMT2D mice, but was not altered in serum. Carnitine and its derivatives were also significantly reduced in spinal cord tissue of mutant mice, whereas glycine was elevated. Dietary supplementation with acetyl-L-carnitine improved gross motor performance of CMT2D mice, but neither acetyl-L-carnitine nor glycine supplementation altered the parameters directly assessing neuropathy. Other metabolite changes suggestive of liver and kidney dysfunction in the CMT2D mice were validated using clinical blood chemistry. These effects were not secondary to the neuromuscular phenotype, as determined by comparison with another, genetically unrelated mouse strain with similar neuromuscular dysfunction. However, these changes do not seem to be causative or consistent metabolites of CMT2D, because they were not observed in a second mouse Gars allele or in serum samples from CMT2D patients. Therefore, the metabolite ‘fingerprint’ we have identified for CMT2D improves our understanding of cellular biochemical changes associated with GARS mutations, but identification of efficacious treatment strategies and elucidation of the disease mechanism will require additional studies.http://bio.biologists.org/content/5/7/908Peripheral neuropathySpinal cordSciatic nerveMetabolomicsMass SpectrometrytRNA synthetase |
| spellingShingle | Preeti Bais Kirk Beebe Kathryn H. Morelli Meagan E. Currie Sara N. Norberg Alexei V. Evsikov Kathy E. Miers Kevin L. Seburn Velina Guergueltcheva Ivo Kremensky Albena Jordanova Carol J. Bult Robert W. Burgess Metabolite profile of a mouse model of Charcot–Marie–Tooth type 2D neuropathy: implications for disease mechanisms and interventions Biology Open Peripheral neuropathy Spinal cord Sciatic nerve Metabolomics Mass Spectrometry tRNA synthetase |
| title | Metabolite profile of a mouse model of Charcot–Marie–Tooth type 2D neuropathy: implications for disease mechanisms and interventions |
| title_full | Metabolite profile of a mouse model of Charcot–Marie–Tooth type 2D neuropathy: implications for disease mechanisms and interventions |
| title_fullStr | Metabolite profile of a mouse model of Charcot–Marie–Tooth type 2D neuropathy: implications for disease mechanisms and interventions |
| title_full_unstemmed | Metabolite profile of a mouse model of Charcot–Marie–Tooth type 2D neuropathy: implications for disease mechanisms and interventions |
| title_short | Metabolite profile of a mouse model of Charcot–Marie–Tooth type 2D neuropathy: implications for disease mechanisms and interventions |
| title_sort | metabolite profile of a mouse model of charcot marie tooth type 2d neuropathy implications for disease mechanisms and interventions |
| topic | Peripheral neuropathy Spinal cord Sciatic nerve Metabolomics Mass Spectrometry tRNA synthetase |
| url | http://bio.biologists.org/content/5/7/908 |
| work_keys_str_mv | AT preetibais metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT kirkbeebe metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT kathrynhmorelli metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT meaganecurrie metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT sarannorberg metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT alexeivevsikov metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT kathyemiers metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT kevinlseburn metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT velinaguergueltcheva metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT ivokremensky metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT albenajordanova metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT caroljbult metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions AT robertwburgess metaboliteprofileofamousemodelofcharcotmarietoothtype2dneuropathyimplicationsfordiseasemechanismsandinterventions |